Featured Firms
Presented by BigVoodoo
Generic drug maker Mylan applied to the FDA to market its own version of the cancer drug Tarceva in 2009, betting that its lawyers at Wiley Rein could fend off infringement claims by asserting that Pfizer's patents for the drug didn't pass muster. The company lost that bet on Tuesday, when lawyers at Kaye Scholer convinced a Delaware judge that the patents are valid.
May 03, 2012 at 12:00 AM
1 minute read
Presented by BigVoodoo
Join General Counsel and Senior Legal Leaders at the Premier Forum Designed For and by General Counsel from Fortune 1000 Companies
Join General Counsel and Senior Legal Leaders at the Premier Forum Designed For and by General Counsel from Fortune 1000 Companies
Honoring outstanding legal achievements focused at the national level, largely around Big Law and in-house departments.
Truly exceptional Bergen County New Jersey Law Firm is growing and seeks strong plaintiff's personal injury Attorney with 5-7 years plaintif...
Epstein Becker & Green is seeking an associate to joins its Commercial Litigation practice in our Columbus or Cincinnati offices. Ca...
McCarter & English, LLP, a well established and growing law firm, is actively seeking a talented and driven associate having 2-5 years o...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS